180 related articles for article (PubMed ID: 36724294)
1. Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides.
Subrahmanyam N; Yathavan B; Yu SM; Ghandehari H
Mol Pharm; 2023 Mar; 20(3):1670-1680. PubMed ID: 36724294
[TBL] [Abstract][Full Text] [Related]
2. HPMA copolymer-collagen hybridizing peptide conjugates targeted to breast tumor extracellular matrix.
Subrahmanyam N; Yathavan B; Kessler J; Yu SM; Ghandehari H
J Control Release; 2023 Jan; 353():278-288. PubMed ID: 36244509
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
5. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
6. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
7. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
Li L; Zhou M; Huang Y
Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
Lu ZR
Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
[TBL] [Abstract][Full Text] [Related]
9. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
Xiang Y; Chen L; Zhou R; Huang Y
Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
[TBL] [Abstract][Full Text] [Related]
10. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
Buckway B; Wang Y; Ray A; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
[TBL] [Abstract][Full Text] [Related]
12. Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.
Fan W; Zhang W; Jia Y; Brusnahan SK; Garrison JC
Mol Pharm; 2017 May; 14(5):1405-1417. PubMed ID: 28263073
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
Mitra A; Mulholland J; Nan A; McNeill E; Ghandehari H; Line BR
J Control Release; 2005 Jan; 102(1):191-201. PubMed ID: 15653145
[TBL] [Abstract][Full Text] [Related]
14. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
Chandran SS; Nan A; Rosen DM; Ghandehari H; Denmeade SR
Mol Cancer Ther; 2007 Nov; 6(11):2928-37. PubMed ID: 18025277
[TBL] [Abstract][Full Text] [Related]
15. N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs.
Nan A; Nanayakkara NP; Walker LA; Yardley V; Croft SL; Ghandehari H
J Control Release; 2001 Dec; 77(3):233-43. PubMed ID: 11733091
[TBL] [Abstract][Full Text] [Related]
16. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.
Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J
J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
19. High Serum Stability of Collagen Hybridizing Peptides and Their Fluorophore Conjugates.
Bennink LL; Smith DJ; Foss CA; Pomper MG; Li Y; Yu SM
Mol Pharm; 2017 Jun; 14(6):1906-1915. PubMed ID: 28445649
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.
Wang D; Sima M; Mosley RL; Davda JP; Tietze N; Miller SC; Gwilt PR; Kopecková P; Kopecek J
Mol Pharm; 2006; 3(6):717-25. PubMed ID: 17140259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]